General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

CommunityPharmacyResearchApril 27 2016

Community pharmacies which undertake practice research programmes report benefits such as increased credibility as a high quality pharmacy service provider, a study has suggested. Active participation in research also can benefit patients and the public with the potential for improved quality of care and patient outcomes.

The advantages of pharmacy participation are included in an evaluation of the Royal Pharmaceutical Society’s community pharmacy Ready Research Programme. This is an accreditation programme which aims to support community pharmacies getting involved in research studies across Great Britain.

Aims of the online programme, which covers the basic requirements for undertaking primary care, are to:

  • ensure pharmacies undertaking the accreditation process meet the standards outlined in the Department of Health’s Research Governance Framework
  • increase the routine involvement of community pharmacies in funded research, with appropriate financial reward for their time;
  • encourage national research infrastructures to select community pharmacies as research sites;
  • provide adequate support for community pharmacies to undertake research and increase opportunities for research.

Since its launch in September 2013, nearly 200 pharmacies have engaged with Research Ready. Feedback from a survey of these pharmacies with 72 responses, found that all research leads were pharmacists, with 81% being RPS members, but only 1% being RPS Faculty members. “It was also evident that the majority of pharmacies were either multiple independents or independent pharmacies, which have between seven and nine staff,” said the Society.

Among the sorts of research activities undertaken by accredited pharmacies have been signposting patients to studies, raising awareness of the importance of health-related research in the NHS, and recruiting patients into studies or formally taking consent from participants and enabling them to take part in a study. Smaller proportions of pharmacies reported having been involved in managing and dispensing clinical trial medication or actively delivering a study intervention.

The evaluation of the programme concluded: “Pharmacy leads identified professional and business development as the most important factors for becoming accredited. Of those that responded, 61% were already involved in research prior to becoming accredited and aware of the benefit research yields to improve patient care.

“The advantages of accreditation for the business included increased credibility as a high quality provider, service development and innovation, and building stronger links with industry and academia. Research leads’ perception as the greatest advantages of the accreditation for patients and the public included, increased accessibility to research and improved quality of care and patient outcomes.”

Dr Rachel Joynes, Head of Research and Evaluation at the RPS, added: “We are keen to demystify research for community pharmacy and break down perceived barriers to research engagement. Research Ready enables pharmacy to engage in research on their own terms in a way that is meaningful and practical for both business and professional development needs.”

Links:

RPS announcement

RPS Community Pharmacy Ready Research Programme

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...